Association of β-Blocker Therapy at Discharge with Clinical Outcomes after Acute Coronary Syndrome in Patients without Heart Failure
Aim. To evaluate the clinical impact of β-blocker in patients with adequate left ventricular ejection function (LVEF) who underwent percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). Methods. A total of 10,724 consecutive patients who underwent PCI throughout 2013 were prosp...
Saved in:
Main Authors: | Yan Chen (Author), Xiao-fang Tang (Author), Run-lin Gao (Author), Yue-jin Yang (Author), Bo Xu (Author), Jin-qing Yuan (Author) |
---|---|
Format: | Book |
Published: |
Hindawi-Wiley,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discharge β-blocker Use and Race after Coronary Artery Bypass Grafting
by: Wesley T. O'Neal, et al.
Published: (2014) -
Prognostic Impacts of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Without Heart Failure
by: Runzhen Chen, et al.
Published: (2022) -
HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA
by: A. A. Aleksandrov, et al.
Published: (2016) -
Outcomes of beta-blocker pharmacotherapy in patients with heart failure
by: Maletin Sanja D., et al.
Published: (2024) -
Beta-Blockers and Oxidative Stress in Patients with Heart Failure
by: Kazufumi Nakamura, et al.
Published: (2011)